-
09-05-2018, 09:58 AM
#16301
Originally Posted by winner69
Haha - and sit around the boardroom table looking at the cash burn?
-
15-05-2018, 07:13 PM
#16302
Close at 31.5
That seems awfully low
“ At the top of every bubble, everyone is convinced it's not yet a bubble.”
-
15-05-2018, 08:48 PM
#16303
Originally Posted by Hectorplains
I have contacted Kaiser asking for clarification on if there has been actual training of urologists and if so what exactly this might mean. I'll be happy to share any response... hopeful it's not in 3 or more years time.
I have chased answers across every contact platform that I could. In the limited response I received, and these were all by phone, Kaiser won't even go as far as to confirm that they are even in negotiation with PEB about anything, anywhere, anytime. They're one superbly non-leaky ship! Sorry, I've drawn a big blank.
-
16-05-2018, 09:48 AM
#16304
Member
It appears to be common practice for large organisations to not reveal any connection to a vendor UNTIL something has been made official from that large organisation. Kaiser won't be unique to this.
In a somewhat small comparison, I've done hundreds of searches on websites using key words, knowing full well other associated parties to that business, and nothing comes up on the search. This is even for established connections, so you can imagine in a case where an established connection is not official that there would be silence of the highest order.
Appreciate your due diligence on this Hectorplains (a phone call is a very pragmatic step); we're all keen to see what eventuates.
-
16-05-2018, 10:30 AM
#16305
Originally Posted by winner69
Close at 31.5
That seems awfully low
now at 33.0... not quite so awfully low
-
16-05-2018, 02:58 PM
#16306
Originally Posted by trader_jackson
now at 33.0... not quite so awfully low
Originally Posted by trader_jackson
Another SSH, another top up, another significant number of shares brought by an insto... Months ago (maybe even years) I did mention the instos/underwriters are buying so much they may well end up owning all of the loss making PEB..
"Ramp 'em up and sell 'em down."
I just haven't seen the sell 'em down part too much
Buyer at 33c ran away rather quickly?
Down down down is the trend - no other trendline visible, short or long term!
Soon, will have a '2' in front of it if Kaiser thingi does not happen.
Last edited by Balance; 16-05-2018 at 03:04 PM.
-
16-05-2018, 03:13 PM
#16307
Originally Posted by Balance
Buyer at 33c ran away rather quickly?
Down down down is the trend - no other trendline visible, short or long term!
Soon, will have a '2' in front of it if Kaiser thingi does not happen.
If the Kaiser thing does not happen then I am afraid PEB will be in more trouble than having a 2 in front of their SP. But if it does happen... well if they can get it before the next capital raise then anything up to $1 is possible.
Last edited by blackcap; 16-05-2018 at 03:15 PM.
-
22-05-2018, 03:15 PM
#16308
https://www.nzx.com/announcements/318301
"Numbers generally in line with expectations".
Except that NOT one number met expectations!
No wonder sp down to 31c.
-
22-05-2018, 03:26 PM
#16309
Originally Posted by Balance
This bit is quite funny if not comical:
o The revenue number in the financial accounts for FY18 will be lower
than under the previous revenue accounting standard:
Under the previous accounting standard as used by Pacific Edge for FY17
financial results, revenue was recognised when tests were performed. This per
test revenue was set using an average of the historic per test revenue that
had been received from a large number of tests completed, for these patients
to date. With the change to the new standard, where revenue for these US
customers will be recognised when the cash is received, there will be a
reduction in the reported sales revenue for these US tests. The change will
mean that Pacific Edge will no longer report accrued test revenue for the US
component of the revenue.
This bit is actually very worrysome if you are a PEB holder:
Pacific Edge's FY18 plan included a small contribution to the
FY18 revenue from Kaiser Permanente however the Company has not yet generated
any sales from Kaiser Permanente. The commercial agreement continues to move
forward however this is taking longer than anticipated to finalise. In
addition, early sales to the Veterans Administration have been lower than
expected.
-
22-05-2018, 03:53 PM
#16310
One good thing there shouldn’t be any bad debts under the new reporting standards ....cause all the bills stay in their ‘billing and reimbursement process’
And cash burn ~$18m ...hmmm
“ At the top of every bubble, everyone is convinced it's not yet a bubble.”
Tags for this Thread
Posting Permissions
- You may not post new threads
- You may not post replies
- You may not post attachments
- You may not edit your posts
-
Forum Rules
|
|
Bookmarks